|
|
Introduction to Ehrlichia spp.
|
|
This page provides brief background
information of Ehrlichiae and Ehrlichiosis modified from review
papers published from the lab.
For more detailed information,
please check publications of our laboratory,
or visit Viral
and Rickettsial Zoonoses Branch: Human Ehrlichiosis in the United
States in Centers for Disease
Control and Prevention (CDC). |
|
|
Ehrlichiae
Ehrlichiae are small gram-negative pleomorphic cocci
that are obligatory intracellular bacteria. Ehrlichiae replicate in the
membrane-bound vacuoles (parasitophorous vacuoles) in the cytoplasm of a
specific type of host cells, chiefly granulocytes or monocytes. Ehrlichial
organisms are vector-borne; they replicate in the tick or the trematode and
are horizontally transmitted from infected cells in vectors to the blood
cells of animals or humans.
Once thought only veterinary pathogens, recently several
Ehrlichia spp. have been recognized as emerging human pathogens in the U.S.
Human monocytic ehrlichiosis (HME), caused by Ehrlichia chaffeensis a new
monocytotropic ehrlichia, was discovered in 1986 and human granulocytic
ehrlichiosis (HGE), caused by the HGE agent (newly named Anaplasma phagocytophilum), a new granulocytotropic ehrlichia,
was discovered in 1994. In 1999 another granulocytotropic ehrlichia, E. ewingii
which was previously known as a canine pathogen has been recognized
as human pathogen. E. sennetsu (renamed to Neorickettsia sennetsu) is another monocytotropic Ehrlichia sp. and
the first human pathogen discovered in Japan in the 1950’s and recently found
in Malaysia.
|
|
|